Description

Cvetiron 100 (quetiapine) Coated Tablets 100 mg. №30

Ingredients:

Active ingredient: Quetiapine fumarate 100 mg per tablet.

Dosage:

Adults: The usual starting dose is 50 mg once daily, which can be increased gradually. The maximum recommended dose is 300 mg per day.

Indications:

Cvetiron 100 (quetiapine) tablets are indicated for the treatment of schizophrenia and bipolar disorder.

Contraindications:

Do not use Cvetiron 100 (quetiapine) tablets if you are allergic to quetiapine or any other ingredients in the product.

Directions:

Take Cvetiron 100 (quetiapine) tablets orally with or without food as directed by your healthcare provider.

Scientific Evidence:

Quetiapine, the active ingredient in Cvetiron 100 tablets, has been extensively studied for its efficacy in managing symptoms of schizophrenia and bipolar disorder. Research published in the Journal of Clinical Psychiatry demonstrated the effectiveness of quetiapine in improving both positive and negative symptoms of schizophrenia compared to placebo.

Additional Information:

It is important to follow the prescribed dosage and not exceed the recommended daily limit. Consult your healthcare provider for personalized advice on the use of Cvetiron 100 tablets.

Pharmacological Effects:

Quetiapine acts as an antagonist at multiple neurotransmitter receptors in the brain, including serotonin and dopamine receptors. By modulating the activity of these neurotransmitters, quetiapine helps to restore the balance of chemicals in the brain, reducing symptoms of psychosis and mood disturbances.

Clinical Trials and Comparative Effectiveness:

Clinical trials have shown that quetiapine is effective in the treatment of acute manic episodes associated with bipolar disorder. In comparative studies, quetiapine has demonstrated similar efficacy to other antipsychotic medications with a more favorable side effect profile in some cases.

Overall, Cvetiron 100 (quetiapine) tablets offer a well-established treatment option for individuals with schizophrenia and bipolar disorder, supported by scientific evidence and clinical trials.